| Nov 15 |
US$8.25: That's What Analysts Think 2seventy bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results
|
| Nov 14 |
2seventy bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 12 |
2seventy bio, Inc. (TSVT) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
2seventy bio GAAP EPS of -$0.19, revenue of $13.53M
|
| Nov 12 |
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 7 |
3 Promising US Penny Stocks With At Least $100M Market Cap
|
| Nov 4 |
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference
|
| Oct 24 |
High Growth Tech Stocks To Watch In October 2024
|
| Sep 25 |
Bristol Myers, 2seventy bio halt enrollment in Abecma late-stage trial
|
